Cardinal Health, Inc. Announces Quarterly Dividend of $0.52 (NYSE:CAH)

Key Points

• Cardinal Health declared a quarterly dividend of $0.5158 per share, payable October 15 to shareholders of record October 1. The dividend yields approximately 0.9%, and the company has raised it for 29 consecutive years.
• Fiscal fourth-quarter adjusted EPS was $2.91, well above the $2.42 analyst estimate, while revenue rose 5.8% year over year to $63.67 billion but fell short of expectations.
• Management issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, above consensus, and authorized an additional $5 billion in share repurchases, supported by continued specialty-pharmaceutical demand.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) declared a quarterly dividend on Tuesday, August 11th. Shareholders of record on Thursday, October 1st will be paid a dividend of 0.5158 per share on Thursday, October 15th. This represents a c) annualized dividend and a yield of 0.9%. The ex-dividend date is Thursday, October 1st.

Cardinal Health has raised its dividend by an average of 0.0%annually over the last three years and has raised its dividend annually for the last 29 consecutive years. Cardinal Health has a dividend payout ratio of 22.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Cardinal Health to earn $12.04 per share next year, which means the company should continue to be able to cover its $2.06 annual dividend with an expected future payout ratio of 17.1%.

Cardinal Health Trading Up 1.2%

Shares of Cardinal Health stock traded up $2.90 during mid-day trading on Tuesday, hitting $240.08. 3,006,020 shares of the stock were exchanged, compared to its average volume of 2,037,982. Cardinal Health has a twelve month low of $137.75 and a twelve month high of $258.30. The company has a 50-day simple moving average of $227.47 and a 200 day simple moving average of $216.44. The stock has a market capitalization of $56.23 billion, a price-to-earnings ratio of 36.71, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities research analysts forecast that Cardinal Health will post 10.77 earnings per share for the current fiscal year.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Profit significantly exceeded expectations. Fiscal fourth-quarter non-GAAP EPS was $2.91, versus the $2.42 analyst consensus and $2.08 a year earlier. Reported EPS growth was helped by a $0.31-per-share benefit from an IEEPA tariff refund, while EPS excluding that benefit still increased 25% to $2.60. Cardinal Health Q4 Earnings Beat Estimates
• Positive Sentiment: Fiscal 2027 guidance topped Wall Street forecasts. Cardinal Health projected non-GAAP EPS of $12.40 to $12.60, representing 13% to 15% growth and exceeding the roughly $12.05 consensus. Management cited sustained specialty-pharmaceutical demand, including strength in cell and gene therapy services. Cardinal Health Forecasts Full-Year Profit Above Estimates
• Positive Sentiment: Capital returns were strengthened. The board authorized an additional $5 billion for share repurchases, following $1.4 billion of buybacks in fiscal 2026. It also approved a quarterly dividend of $0.5158 per share, supporting the stock’s income and shareholder-return appeal. Cardinal Health Fiscal 2026 Results and Guidance
• Neutral Sentiment: Fourth-quarter revenue rose 6% year over year to $63.67 billion, but remained below the approximately $65.15 billion analyst estimate. Investors are weighing this mixed top-line performance against expectations for revenue growth in both major business segments during fiscal 2027.
• Negative Sentiment: The earnings quality was somewhat mixed because the quarter benefited from a one-time tariff refund, while Cardinal Health continues to operate with a very thin net margin.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source